文献速递静脉血栓栓塞慢性静脉疾病

浅静脉血栓患者中癌症患病率及其临床重要性

Prevalence of cancer in patients with superficial vein thrombosis and its clinical importance.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-06-02

这项单中心回顾性研究纳入2006至2018年276例腿部症状性浅静脉血栓(SVT)患者,评估癌症患病率及并发深静脉血栓(DVT)/肺栓塞(PE)的决定因素。全组癌症患病率为8.7%,孤立性SVT为4.2%,并发DVT/PE者为18.8%(P < .001)。癌症是并发DVT/PE的最强决定因素(OR 4.727)。

要点

  • SVT患者中癌症患病率为8.7%,以乳腺癌和泌尿道癌为主。
  • 并发DVT/PE的SVT患者癌症患病率显著高于孤立性SVT(18.8% vs 4.2%)。
  • 癌症是SVT患者并发DVT/PE的最强决定因素(OR 4.727)。

核心结论

  • SVT患者中癌症患病率为8.7%,癌症是并发DVT/PE的最强决定因素。

研究设计与样本

  • 单中心、回顾性研究,前瞻性收集2006至2018年三级医疗中心血栓门诊的276例腿部症状性SVT患者数据。

主要发现

  • 全组癌症患病率为8.7%,主要为乳腺癌和泌尿道癌。
  • 孤立性SVT患者癌症患病率为4.2%,并发DVT/PE者为18.8%(P < .001)。
  • logistic回归显示与并发DVT/PE显著相关的因素包括年龄(OR 1.024,95%CI 1.004-1.044)、女性(OR 0.545,95%CI 0.309-0.960)、静脉曲张性SVT(OR 0.42,95%CI 0.194-0.902)、血栓形成倾向(OR 1.939,95%CI 1.089-3.454)和癌症(OR 4.727,95%CI 1.814-12.316)。

关键数值与推荐

  • 癌症定义为SVT诊断前12个月内诊断和/或正在接受治疗。
  • SVT并发DVT/PE的独立相关因素:年龄、女性、静脉曲张性SVT、血栓形成倾向、癌症。

临床怎么用

  • 对SVT患者应评估癌症风险,尤其当并发DVT/PE时癌症患病率更高。
  • 年龄、血栓形成倾向、男性、非静脉曲张性SVT和癌症与并发DVT/PE相关,可用于风险分层。

局限性

  • 单中心回顾性研究,样本量有限,结论需外推验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of the present study was to evaluate the prevalence of cancer in patients with superficial vein thrombosis (SVT) of the legs. Moreover, we evaluated the potential determinants of SVT complications by comparing a subgroup with isolated SVT and a subgroup of SVT complicated by concurrent deep vein thrombosis (DVT) and/or pulmonary embolism (PE) with respect to the presence of cancer and other clinical and laboratory characteristics. METHODS: The present single-center, retrospective study of prospectively collected data was conducted in a tertiary care setting. We included patients who had been treated in the thrombosis clinic from 2006 to 2018 for symptomatic SVT of the legs, either isolated SVT or SVT complicated by concurrent DVT/PE. We evaluated the prevalence and type of malignancy (diagnosed ≤12 months before SVT and/or ongoing therapy), demographics, and clinical and laboratory characteristics of the patients. For statistical evaluation, we used the Student t test, Kruskal-Wallis test, Fisher exact two-sided test, and logistic regression. RESULTS: Of 276 patients with SVT (mean age, 58.9 ± 14.7 years; 60.9% women), 191 had had isolated SVT and 85 had had SVT complicated by concurrent DVT/PE. The prevalence of malignancy was 8.7% in the whole group (mainly breast and urinary tract cancer), including 4.2% of those with isolated SVT and 18.8% of those with SVT and concurrent DVT/PE (P < .001). Between the two subgroups, no significant differences were present in the duration of leg symptoms, family or personal history of SVT and/or DVT, SVT location, and smoking. In logistic regression, several factors were significantly associated with the concurrent presence of DVT/PE: age (odds ratio [OR], 1.024; 95% confidence interval [CI], 1.004-1.044), female gender (OR, 0.545; 95% CI, 0.309-0.960), varicose vein SVT (OR, 0.42; 95% CI, 0.194-0.902), thrombophilia (OR, 1.939; 95% CI, 1.089-3.454), and cancer (OR, 4.727; 95% CI, 1.814-12.316). CONCLUSIONS: The prevalence of malignancy in the patients with SVT was 8.7%. Age, thrombophilia, male gender, nonvaricose vein SVT, and cancer were significantly associated with the presence of concurrent DVT/PE. Cancer was the strongest determinant of concurrent DVT/PE.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Hirmerová J, Seidlerová J, Šubrt I, et al. Prevalence of cancer in patients with superficial vein thrombosis and its clinical importance. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34089942. doi:10.1016/j.jvsv.2021.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。